In accordance with Centers for Medicare and Medicaid Services (CMS) policy, for dates of service on or after July 1, 2023, Point32Health now requires providers to append modifier JW or JZ when reporting a drug from a single-dose vial or package.
As a reminder, modifier JW should be reported when there is drug waste from a single-dose vial or package, while modifier JZ should be reported when there is no drug waste.
Point32Health has updated our Modifier Payment Policy to reflect this new billing requirement.
Director, Provider Relations & Communications
Senior Manager, Provider Communications
Joseph O’Riordan, Susan Panos, Stephen Wong,